Literature DB >> 15025184

Azathioprine transport through rat skin and its immunosuppressive effect.

B M Tashtoush1, S A Al-Safi, K J Al-Fanek.   

Abstract

The objective of this research was to study the in vitro and in vivo percutaneous absorption of azathioprine with and without the effect of penetration enhancers. In vitro permeation of azathioprine was studied using a Franz diffusion cell and rat skin. Both azathioprine and 6-mercaptopurine were detected in the receiver solution with a reversed phase HPLC system. The steady state flux of azathioprine, permeability coefficient, and lag time were reported. Penetration enhancers such as dimethylsulfoxide (DMSO), dimethylformamide (DMF), and urea were added to the donor compartment to increase the skin permeation of azathioprine. The flux of azathioprine was increased by 20.7%, and 22.4% using dimethylsulfoxide, and dimethylformamide respectively. The in vivo permeation was determined by measurement of antibody titers by the slide latex agglutination test. The in vivo permeation study showed that the titers of antibody induced in the rats were not affected by topical application of azathioprine solution. The results show that azathioprine has low flux to exert a systemic effect with and without penetration enhancers. However these results may support the use of topical azathioprine for the treatment of some dermatological disorders with minimum side effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025184

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

1.  Efficacy of topical azathioprine and betamethasone versus betamethasone-only emollient cream in 2-18 years old patients with moderate-to-severe atopic dermatitis: A randomized controlled trial.

Authors:  Fariba Iraji; Sadaf Farhadi; Gita Faghihi; Fatemeh Mokhtari; Akram Basiri; Tohid Jafari-Koshki; Mohammad Ali Nilforoushzadeh
Journal:  Adv Biomed Res       Date:  2015-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.